Insider Transactions in Q3 2023 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.03%
|
$240,000
$48.11 P/Share
|
|
Sep 21
2023
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.93%
|
$30,000
$6.36 P/Share
|
|
Sep 19
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
400,000
+50.0%
|
$10,400,000
$26.0 P/Share
|
|
Sep 13
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
1,682
-0.36%
|
$84,100
$50.34 P/Share
|
|
Sep 13
2023
|
Timothy Rolph Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
531
-0.35%
|
$26,550
$50.34 P/Share
|
|
Sep 13
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
617
-1.32%
|
$30,850
$50.34 P/Share
|
|
Sep 13
2023
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
632
-3.31%
|
$31,600
$50.34 P/Share
|
|
Sep 13
2023
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
562
-0.31%
|
$28,100
$50.34 P/Share
|
|
Sep 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.56%
|
$1,250,000
$50.01 P/Share
|
|
Sep 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.88%
|
$150,000
$6.36 P/Share
|
|
Aug 30
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+3.14%
|
$0
$0.62 P/Share
|
|
Aug 28
2023
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,745
-5.54%
|
$287,250
$50.29 P/Share
|
|
Aug 28
2023
|
Catriona Yale Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,745
+9.89%
|
$34,470
$6.36 P/Share
|
|
Aug 08
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
25,000
+4.0%
|
$1,050,000
$42.06 P/Share
|
|
Aug 01
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.68%
|
$1,075,000
$43.18 P/Share
|
|
Aug 01
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.02%
|
$150,000
$6.36 P/Share
|
|
Aug 01
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
25,000
+4.17%
|
$1,075,000
$43.26 P/Share
|
|
Jul 28
2023
|
G. Walmsley Graham |
BUY
Open market or private purchase
|
Indirect |
30,000
+5.17%
|
$1,260,000
$42.69 P/Share
|
|
Jul 03
2023
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.78%
|
$1,125,000
$45.44 P/Share
|
|
Jul 03
2023
|
Andrew Cheng President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.02%
|
$150,000
$6.36 P/Share
|